Point72 Hong Kong’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,428
| Closed | -$68.5K | – | 543 |
|
|
2023
Q4 | $68.5K | Buy |
+11,428
| New | +$68.5K | ﹤0.01% | 497 |
|
|
2022
Q4 | – | Sell |
-18,428
| Closed | -$232K | – | 183 |
|
|
2022
Q3 | $232K | Buy |
+18,428
| New | +$232K | 0.01% | 525 |
|
|
2022
Q2 | – | Sell |
-7,265
| Closed | -$118K | – | 1462 |
|
|
2022
Q1 | $118K | Buy |
+7,265
| New | +$118K | ﹤0.01% | 621 |
|
|
2021
Q4 | – | Sell |
-1,981
| Closed | -$28K | – | 1344 |
|
|
2021
Q3 | $28K | Buy |
+1,981
| New | +$28K | ﹤0.01% | 1029 |
|
|
2021
Q2 | – | Sell |
-4,618
| Closed | -$47K | – | 1366 |
|
|
2021
Q1 | $47K | Buy |
4,618
+350
| +8% | +$3.56K | ﹤0.01% | 782 |
|
|
2020
Q4 | $32K | Buy |
+4,268
| New | +$32K | ﹤0.01% | 863 |
|
|
2020
Q3 | – | Sell |
-7,184
| Closed | -$34K | – | 1194 |
|
|
2020
Q2 | $34K | Buy |
7,184
+4,426
| +160% | +$20.9K | ﹤0.01% | 799 |
|
|
2020
Q1 | $6K | Buy |
2,758
+204
| +8% | +$444 | ﹤0.01% | 755 |
|
|
2019
Q4 | $9K | Buy |
+2,554
| New | +$9K | ﹤0.01% | 977 |
|
|
2019
Q2 | – | Sell |
-2,507
| Closed | -$20K | – | 1122 |
|
|
2019
Q1 | $20K | Buy |
2,507
+2,307
| +1,154% | +$18.4K | 0.01% | 673 |
|
|
2018
Q4 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 720 |
|